Average Co-Inventor Count = 3.75
ph-index = 1
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Dana-farber-cancer Institute Inc. (19 from 1,209 patents)
2. Cornell University (3 from 1,361 patents)
3. Voronoi Inc. (3 from 9 patents)
4. Children's Medical Center Corporation (1 from 1,036 patents)
19 patents:
1. 12497398 - Potent and selective covalent inhibitors of serine-arginine protein kinase (SRPK) 1 and SRPK2 and uses thereof
2. 12479847 - Pyrrolopyrimidine inhibitors of wild-type and mutant forms of LRRK2
3. 12410194 - Potent and selective azaindole inhibitors of CDK8 and CDK19
4. 12325725 - Cyclin-dependent kinase degraders and methods of use
5. 12275731 - Azaindole inhibitors of wild-type and mutant forms of LRRK2
6. 12233128 - Degraders that target ALK and therapeutic uses thereof
7. 12157738 - Macrocyclic inhibitors of ALK, TRKA, TRKB, and ROS1
8. 12157741 - Macrocyclic inhibitors of DYRK1A
9. 11945816 - Inhibitors of EGFR and/or HER2 and methods of use
10. 11858897 - Substituted 6,11-dihydro-5H-benzo[b]carbazoles as inhibitors of ALK and SRPK
11. 11542251 - IRAK degraders and uses thereof
12. 11248007 - Inhibitors of MALT1 and uses thereof
13. 11186574 - Inhibitors of EGFR and/or HER2 and methods of use
14. 11066363 - Substituted 6,11-dihydro-5H-benzo[B]carbazoles as inhibitors of ALK and SRPK
15. 10975055 - Inhibitors of interleukin-1 receptor-associated kinases and uses thereof